Skip to main content
Journal cover image

Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma.

Publication ,  Journal Article
Nair, SK; Driscoll, T; Boczkowski, D; Schmittling, R; Reynolds, R; Johnson, LA; Grant, G; Fuchs, H; Bigner, DD; Sampson, JH; Gururangan, S ...
Published in: J Neurooncol
October 2015

Generation of patient-derived, autologous dendritic cells (DCs) is a critical component of cancer immunotherapy with ex vivo-generated, tumor antigen-loaded DCs. An important factor in the ability to generate DCs is the potential impact of prior therapies on DC phenotype and function. We investigated the ability to generate DCs using cells harvested from pediatric patients with medulloblastoma for potential evaluation of DC-RNA based vaccination approach in this patient population. Cells harvested from medulloblastoma patient leukapheresis following induction chemotherapy and granulocyte colony stimulating factor mobilization were cryopreserved prior to use in DC generation. DCs were generated from the adherent CD14+ monocytes using standard procedures and analyzed for cell recovery, phenotype and function. To summarize, 4 out of 5 patients (80%) had sufficient monocyte recovery to permit DC generation, and we were able to generate DCs from 3 out of these 4 patient samples (75%). Overall, we successfully generated DCs that met phenotypic requisites for DC-based cancer therapy from 3 out of 5 (60%) patient samples and met both phenotypic and functional requisites from 2 out of 5 (40%) patient samples. This study highlights the potential to generate functional DCs for further clinical treatments from refractory patients that have been heavily pretreated with myelosuppressive chemotherapy. Here we demonstrate the utility of evaluating the effect of the currently employed standard-of-care therapies on the ex vivo generation of DCs for DC-based clinical studies in cancer patients.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Neurooncol

DOI

EISSN

1573-7373

Publication Date

October 2015

Volume

125

Issue

1

Start / End Page

65 / 74

Location

United States

Related Subject Headings

  • Viral Matrix Proteins
  • Transduction, Genetic
  • Survivin
  • Phosphoproteins
  • Peptide Fragments
  • Oncology & Carcinogenesis
  • Monocytes
  • Medulloblastoma
  • Leukapheresis
  • Inhibitor of Apoptosis Proteins
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nair, S. K., Driscoll, T., Boczkowski, D., Schmittling, R., Reynolds, R., Johnson, L. A., … Mitchell, D. A. (2015). Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma. J Neurooncol, 125(1), 65–74. https://doi.org/10.1007/s11060-015-1890-2
Nair, Smita K., Timothy Driscoll, David Boczkowski, Robert Schmittling, Renee Reynolds, Laura A. Johnson, Gerald Grant, et al. “Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma.J Neurooncol 125, no. 1 (October 2015): 65–74. https://doi.org/10.1007/s11060-015-1890-2.
Nair SK, Driscoll T, Boczkowski D, Schmittling R, Reynolds R, Johnson LA, et al. Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma. J Neurooncol. 2015 Oct;125(1):65–74.
Nair, Smita K., et al. “Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma.J Neurooncol, vol. 125, no. 1, Oct. 2015, pp. 65–74. Pubmed, doi:10.1007/s11060-015-1890-2.
Nair SK, Driscoll T, Boczkowski D, Schmittling R, Reynolds R, Johnson LA, Grant G, Fuchs H, Bigner DD, Sampson JH, Gururangan S, Mitchell DA. Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma. J Neurooncol. 2015 Oct;125(1):65–74.
Journal cover image

Published In

J Neurooncol

DOI

EISSN

1573-7373

Publication Date

October 2015

Volume

125

Issue

1

Start / End Page

65 / 74

Location

United States

Related Subject Headings

  • Viral Matrix Proteins
  • Transduction, Genetic
  • Survivin
  • Phosphoproteins
  • Peptide Fragments
  • Oncology & Carcinogenesis
  • Monocytes
  • Medulloblastoma
  • Leukapheresis
  • Inhibitor of Apoptosis Proteins